EUVIMEDEUVIMED entdecken
Crossref

Phytochemistry and Pharmacological Properties of the Genus Nepeta Documented Between 2021 and 2025

Kashif Ali, Sudais Ahmed, Asif Ali, Xiaoning Dong, Chang Liu, Bushra Fatima, Douglas Law, Manzoor Hussain, Iftikhar Ali

ChemistrySelect · 2026-05 · 11 (18)

DOI: 10.1002/slct.202600049 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemistrySelect, online erschienen am 12.05.2026. Verfasst von Kashif Ali und 8 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 112 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The genus Nepeta encompasses over 296 accepted species widely distributed across Asia, Europe, and North Africa. This review offers a foundation for future pharmacological, phytochemical, and clinical investigations into this underexplored genus. This review critically examines studies published between 2021 and 2025, focusing on the phytochemical diversity, pharmacological properties, and medicinal relevance of Nepeta species. The databases, such as Scifinder, PubMed, PubChem, Taylor & Francis Online, ScienceDirect, Springer, and Google Scholar, were used for the collection of research articles about the focused genus, Nepeta . In the current study, numerous bioactive compounds, already reported, have been documented, including nepetalactones, iridoid glycosides, flavonoids, and terpenoids, which are responsible for a broad spectrum of biological activities. These include antioxidant, anticancer, anti‐inflammatory, and enzyme inhibitory effects as validated through in vitro and in vivo models. The therapeutic applications of Nepeta extracts and essential oils are further supported by ethnobotanical records and pharmacological evidence, underscoring the potential of Nepeta species in drug discovery and integrative medicine. Despite promising outcomes, the literature reveals a lack of clinical studies, standardized assays, and comprehensive toxicity profiles, which are essential for the translational development of Nepeta ‐derived therapeutics.

Zitieren

APA

Ali, K., Ahmed, S., Ali, A., Dong, X., Liu, C., Fatima, B., Law, D., Hussain, M., & Ali, I. (2026). Phytochemistry and Pharmacological Properties of the Genus Nepeta Documented Between 2021 and 2025. ChemistrySelect, 11(18). https://doi.org/10.1002/slct.202600049

Vancouver

Ali K, Ahmed S, Ali A, Dong X, Liu C, Fatima B, et al. Phytochemistry and Pharmacological Properties of the Genus Nepeta Documented Between 2021 and 2025. ChemistrySelect. 2026;11(18). doi:10.1002/slct.202600049

BibTeX
@article{Ali2026,
  author = {Ali, Kashif and Ahmed, Sudais and Ali, Asif and Dong, Xiaoning and Liu, Chang and Fatima, Bushra and Law, Douglas and Hussain, Manzoor and Ali, Iftikhar},
  title = {Phytochemistry and Pharmacological Properties of the Genus Nepeta Documented Between 2021 and 2025},
  journal = {ChemistrySelect},
  year = {2026},
  volume = {11},
  number = {18},
  doi = {10.1002/slct.202600049}
}
Kostenlos starten →